Skip to main content
About Pfizer Ignite
Our services
Overview
Pre-clinical research & development
Clinical development
Clinical supply and manufacturing
Cross-cutting platforms
Expert advisory network
Partnerships and Announcements
Contact
Home
Partnerships and Announcements
Announcements
Category
Announcements
Partners
Announcements
Partners
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer
Carrick Therapeutics Announces $35 Million Investment from Pfizer
Anokion Announces $35 Million Equity Investment from Pfizer
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer